Company Quick10K Filing
flooidCX
Price0.16 EPS-0
Shares136 P/E-11
MCap22 P/FCF-29
Net Debt-0 EBIT-2
TEV22 TEV/EBIT-11
TTM 2019-05-31, in MM, except price, ratios
10-Q 2020-11-30 Filed 2021-01-14
10-Q 2020-08-31 Filed 2020-10-20
10-Q 2020-05-31 Filed 2020-07-15
10-K 2020-02-28 Filed 2020-06-16
10-Q 2019-11-30 Filed 2020-01-17
10-Q 2019-08-31 Filed 2019-10-15
10-Q 2019-05-31 Filed 2019-07-15
10-K 2019-02-28 Filed 2019-06-13
10-Q 2018-11-30 Filed 2019-01-14
10-Q 2018-08-31 Filed 2018-10-15
10-Q 2018-05-31 Filed 2018-07-13
10-K 2018-02-28 Filed 2018-05-29
10-Q 2017-11-30 Filed 2018-01-16
10-Q 2017-08-31 Filed 2017-10-13
10-Q 2017-05-31 Filed 2017-07-17
10-K 2017-02-28 Filed 2017-06-14
10-Q 2016-11-30 Filed 2017-01-17
10-Q 2016-08-31 Filed 2016-10-20
10-Q 2016-05-31 Filed 2016-06-17
10-K 2016-02-29 Filed 2016-05-31
10-Q 2015-11-30 Filed 2016-01-13
10-Q 2015-08-31 Filed 2015-09-16
10-Q 2015-05-31 Filed 2015-07-09
10-K 2015-02-28 Filed 2015-05-18
10-Q 2014-11-30 Filed 2015-01-06
10-Q 2014-08-31 Filed 2014-10-01
8-K 2021-01-27
8-K 2020-08-25
8-K 2020-02-24
8-K 2019-05-17
8-K 2019-04-15
8-K 2019-03-18
8-K 2017-11-27

GRPV 10Q Quarterly Report

Part I. Financial Information
Item 1. Interim Condensed Combined Financial Statements
Item 2. Management's Discussion and Analysis of Financial Conditions and Results of Operations.
Item 3. Qualitative and Quntitative Disclosure About Market Risks
Item 4. Controls and Procedures
Part II - Other Information
Item 1. Legal Proceedings
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds
Item 3. Default Upon Senior Securities
Item 4. Mine Safety Disclosures
Item 5. Other Information
Item 6. Exhibits and Reports on Form 8-K
EX-31.1 grpv_ex311.htm
EX-31.2 grpv_ex312.htm
EX-32.1 grpv_ex321.htm

flooidCX Earnings 2017-08-31

Balance SheetIncome StatementCash Flow
0.3-0.4-1.2-1.9-2.7-3.42014201620182020
Assets, Equity
0.0-0.4-0.8-1.1-1.5-1.92012201420162019
Rev, G Profit, Net Income
0.50.1-0.3-0.7-1.1-1.52014201620182020
Ops, Inv, Fin

10-Q 1 grpv_10q.htm FORM 10-Q grpv_10q.htm

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 10-Q

 

x QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the quarterly period ended August 31, 2017

 

OR

 

¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the transition period from ______________ to ______________

 

Commission File No. 333-1921663

 

GRIPEVINE INC.

(Exact Name of Small Business Issuer as specified in its charter)

 

Nevada

35-2511643

(State or Other Jurisdiction

of Incorporation or Organization)

(I.R.S. Employer

Identification No.)

 

1282A Cornwall Road

Oakville, Ontario

Canada

 

L6J 7W5

(Address of principal executive offices)

 

(Zip Code)

 

(855) 474-7384

Registrant’s telephone number, including area code

 

Not applicable

Former name, former address and former fiscal year, if changed since last report

 

Check whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes x No ¨.

 

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes x No ¨ 

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company.

 

Large accelerated filer

¨

Accelerated filer

o

Non-accelerated filer

¨

Smaller reporting company

x

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ¨ No x

 

Indicate the number of shares outstanding of each of the issuer’s classes of common stock, as of the most practicable date:

 

Class

 

Outstanding as of October 13, 2017

Common Stock, $0.001

 

124,720,532

 

 
 

GRIPEVINE INC. (FORMERLY BAIXO RELOCATION SERVICES, INC.)

FORM 10-Q

FOR THE PERIOD ENDED AUGUST 31, 2017

 

INDEX

 

 

 
2
 
Table of Contents

 

Forward-looking Statements

 

Information included in this Form 10-Q contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended (“Securities Act”), and Section 21E of the Securities Exchange Act of 1934, as amended (“Exchange Act”). This information may involve known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of Gripevine, Inc. (the “Company”), to be materially different from future results, performance or achievements expressed or implied by any forward-looking statements. Forward-looking statements, which involve assumptions and describe future plans, strategies and expectations of the Company, are generally identifiable by use of the words “may,” “will,” “should,” “expect,” “anticipate,” “estimate,” “believe,” “intend,” or “project” or the negative of these words or other variations on these words or comparable terminology. These forward-looking statements are based on assumptions that may be incorrect, and there can be no assurance that these projections included in these forward-looking statements will come to pass. Actual results of the Company could differ materially from those expressed or implied by the forward-looking statements as a result of various factors. Except as required by applicable laws, the Company has no obligation to update publicly any forward-looking statements for any reason, even if new information becomes available or other events occur in the future.

 

 
3
 
Table of Contents

 

PART I. FINANCIAL INFORMATION

 

ITEM 1. INTERIM CONDENSED COMBINED FINANCIAL STATEMENTS

 

Condensed Combined Financial Statements

 

Gripevine, Inc.

 

For The Quarterly Period Ended August 31, 2017

 

 
4
 
Table of Contents

 

Gripevine, Inc.

Interim Condensed Combined Financial Statements

For The Quarterly Period Ended August 31, 2017 (Unaudited)

 

Table of contents

 

Interim Condensed Combined Balance Sheets

 

F-2

 

 

 

 

 

Interim Condensed Combined Statements of Operations and Comprehensive Loss

 

F-3

 

 

 

 

 

Interim Condensed Combined Statements of Cash Flows

 

F-4

 

 

 

 

 

Notes to Interim Condensed Combined Financial Statements

 

F-5

 

 

 
F-1
 
Table of Contents

 

Gripevine, Inc.

INTERIM CONDENSED COMBINED BALANCE SHEETS

AS AT AUGUST 31, 2017 (UNAUDITED) AND FEBRUARY 28, 2017 (AUDITED)

(Expressed in US dollars)

 

 

 

As at

August 31,

2017

 

 

As at

February 28,

2017

 

 

 

$

 

 

$

 

CURRENT ASSETS

 

 

 

 

 

 

Cash

 

 

153,657

 

 

 

32,678

 

Prepaid and other receivables

 

 

12,840

 

 

 

20,281

 

Total current assets

 

 

166,497

 

 

 

52,959

 

 

 

 

 

 

 

 

 

 

Equipment [Note 5]

 

 

41,293

 

 

 

41,655

 

TOTAL ASSETS

 

 

207,790

 

 

 

94,614

 

 

 

 

 

 

 

 

 

 

CURRENT LIABILITIES

 

 

 

 

 

 

 

 

Accounts payable

 

 

33,371

 

 

 

22,325

 

Accrued liabilities

 

 

31,804

 

 

 

78,827

 

Loans payable [Note 6]

 

 

2,185,217

 

 

 

1,822,953

 

Due to related parties [Note 6]

 

 

179,815

 

 

 

178,906

 

Due to a shareholder [Note 6]

 

 

668,170

 

 

 

568,547

 

TOTAL LIABILITIES

 

 

3,098,377

 

 

 

2,671,558

 

 

 

 

 

 

 

 

 

 

STOCKHOLDERS' DEFICIENCY

 

 

 

 

 

 

 

 

Preferred stock, $0.001 par value, 20,000,000 authorized. 1,000,000 shares issued and outstanding as at August 31, 2017 and February 28, 2017 [Note 7]

 

 

1,000

 

 

 

1,000

 

Common stock, $0.001 par value, 300,000,000 authorized, 120,000,000 shares issued and outstanding as at August 31, 2017 and February 28, 2017 [Note 7]

 

 

120,000

 

 

 

120,000

 

Common stock to be issued [Note 7]

 

 

6,694

 

 

 

5,249

 

Additional paid-in-capital

 

 

44,791,629

 

 

 

43,698,125

 

Accumulated other comprehensive income

 

 

49,667

 

 

 

233,651

 

Accumulated deficit

 

 

(47,859,577 )

 

 

(46,634,969 )

Total stockholders' deficiency

 

 

(2,890,587 )

 

 

(2,576,944 )

TOTAL LIABILITIES AND STOCKHOLDERS' DEFICIENCY

 

 

207,790

 

 

 

94,614

 

 

Commitments [Note 9]

 

Subsequent events [Note 10]

 

See accompanying notes to interim condensed combined financial statements

 

 
F-2
 
Table of Contents

 

Gripevine, Inc.

INTERIM CONDENSED COMBINED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS

FOR THE THREE AND SIX MONTHS ENDED AUGUST 31, 2017 AND 2016 (UNAUDITED)

(Expressed in US dollars)

 

 

 

For the Three Months Ended August 31,

2017

 

 

For the Three Months Ended August 31,

2016

 

 

For the Six

Months Ended August 31,

2017

 

 

For the Six

Months Ended August 31,

2016

 

 

 

$

 

 

$

 

 

$

 

 

$

 

 

 

 

 

 

 

 

 

 

 

 

 

 

REVENUE

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

EXPENSES

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Stock based compensation [Note 7]

 

 

588,970

 

 

 

9,673,604

 

 

 

588,970

 

 

 

19,347,207

 

Research and development expenses [Note 8]

 

 

202,130

 

 

 

270,586

 

 

 

453,082

 

 

 

460,152

 

General and administrative expenses

 

 

85,903

 

 

 

144,700

 

 

 

182,556

 

 

 

212,428

 

TOTAL OPERATING EXPENSES

 

 

877,003

 

 

 

10,088,890

 

 

 

1,224,608

 

 

 

20,019,787

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Income taxes

 

 

 

 

 

 

 

 

 

 

 

 

NET LOSS

 

 

877,003

 

 

 

10,088,890

 

 

 

1,224,608

 

 

 

20,019,787

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Translation adjustment

 

 

(232,279 )

 

 

(21,478 )

 

 

(183,984 )

 

 

2,939

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

COMPREHENSIVE LOSS

 

 

644,724

 

 

 

10,067,412

 

 

 

1,040,624

 

 

 

20,022,726

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

LOSS PER SHARE, BASIC AND DILUTED

 

 

0.007

 

 

 

0.084

 

 

 

0.010

 

 

 

0.167

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

WEIGHTED AVERAGE NUMBER OF COMMON SHARES OUTSTANDING

 

 

120,000,000

 

 

 

120,000,000

 

 

 

120,000,000

 

 

 

120,000,000

 

 

See accompanying notes to interim condensed combined financial statements

 

 
F-3
 
Table of Contents

 

Gripevine, Inc.

INTERIM CONDENSED COMBINED STATEMENTS OF CASH FLOWS

FOR THE SIX MONTHS ENDED AUGUST 31, 2017 AND 2016 (UNAUDITED)

(Expressed in US dollars)

 

 

For the Six Months Ended

August 31,

2017

 

 

For the Six Months Ended

August 31,

2016

 

 

 

$

 

 

$

 

CASH FLOWS FROM OPERATING ACTIVITIES

 

 

 

 

 

 

Net loss

 

 

(1,224,608 )

 

 

(20,019,787 )

Adjustments to reconcile net loss to net cash used in operating activities:

 

 

 

 

 

 

 

 

Stock based compensation

 

 

588,970

 

 

 

19,347,207

 

Depreciation

 

 

11,917

 

 

 

5,346

 

 

 

 

 

 

 

 

 

 

Changes in operating assets and liabilities:

 

 

 

 

 

 

 

 

Prepaid expenses and other receivables

 

 

7,926

 

 

 

(15,805 )

Accounts payable

 

 

9,345

 

 

 

1,500

 

Accrued liabilities

 

 

(49,048 )

 

 

(3,852 )

Net cash used in operating activities

 

 

(655,498 )

 

 

(685,391 )

 

 

 

 

 

 

 

 

 

CASH FLOWS FROM INVESTING ACTIVITIES

 

 

 

 

 

 

 

 

Purchase of equipment

 

 

(9,318 )

 

 

(14,589 )

Net cash used in investing activities

 

 

(9,318 )

 

 

(14,589 )

 

 

 

 

 

 

 

 

 

CASH FLOWS FROM FINANCING ACTIVITIES

 

 

 

 

 

 

 

 

Proceeds from issuance of shares

 

 

505,980

 

 

 

 

Loans payable

 

 

240,219

 

 

 

602,972

 

Due to related parties

 

 

(8,818 )

 

 

(70,480 )

Due to a shareholder

 

 

64,099

 

 

 

154,308

 

Net cash provided by financing activities

 

 

801,480

 

 

 

686,800

 

 

 

 

 

 

 

 

 

 

Net increase (decrease) in cash during the period/year

 

 

136,664

 

 

 

(13,180 )

 

 

 

 

 

 

 

 

 

Effect of foreign currency translation

 

 

(15,685 )

 

 

134

 

 

 

 

 

 

 

 

 

 

Cash, beginning of period/year

 

 

32,678

 

 

 

23,926

 

Cash, end of period/year

 

 

153,657

 

 

 

10,880

 

 

See accompanying notes to interim condensed combined financial statements

 

 
F-4
 
Table of Contents

 

Gripevine, Inc.

Notes to Interim Condensed Combined Financial Statements

For The Six Months Ended August 31, 2017

(Expressed in US dollars)

 

1. NATURE OF OPERATIONS

 

Gripevine, Inc. (formerly Baixo Relocation Services, Inc. (the "Company") was incorporated in the state of Nevada on January 7, 2014. The Company operated as a relocation service provider for clients moving to the State of Goa, India and ceased this business and engaged in developing and building an online resolution platform after the Share Exchange Agreement as explained in the subsequent paragraphs. The Company's fiscal year-end is February end.

 

MBE Holdings Inc. (“MBE”) was incorporated as a limited liability company on April 13, 2010 under the laws of the State of Delaware. MBE is engaged in research and development activities to offer an online complaint resolution platform for consumers and business, including ratings, reviews and polling’s. As such, its efforts to date have been devoted in building technology that enables access to this market through the development of a tangible product.

 

As explained in Note 7 to the combined financial statements, on February 28, 2017, the Company and MBE and the shareholders of MBE who collectively own 100% of MBE entered into and consummated transactions pursuant to a Share Exchange Agreement, whereby the Company agreed to issue to the MBE shareholders an aggregate of approximately 5,248,626 shares of its common stock, par value $0.001, in exchange for 100% of equity interests of MBE held by the MBE shareholders. As a result of the share exchange, MBE became a wholly owned subsidiary of Gripevine.

 

As a result of the Share Exchange Agreement, the acquisition transaction has been accounted for as a common control transaction in accordance with the Financial Accounting Standards Board (ASC 805-50, Business Combinations – Common control transactions). The Company has evaluated the guidance contained in ASC 805 with respect to the combinations among entities or businesses under common control and conclude that since the majority shareholder of the Company and MBE are same, therefore, this is a common control transaction and do not result in a change in control at the ultimate parent or the controlling shareholder level.

 

Consequently, common control transactions are not accounted for at fair value. Rather, common control transactions are generally accounted for at the carrying amount of the net assets or equity interests transferred. Any differences between the proceeds received or transferred and the carrying amounts of the net assets are considered equity transactions that would be eliminated in consolidation, and no gain or loss would be recognized in the financial statements of the ultimate parent. Resultantly, the financial position and the results of operations of Gripevine and MBE are combined together as if they were operating as one entity from the beginning.

 

2. BASIS OF PRESENTATION AND COMBINATION

 

The accompanying unaudited condensed combined financial statements have been prepared in accordance with accounting principles generally accepted in the United States (“US GAAP”) for interim financial information and the Securities Exchange Commission (“SEC”) instructions to Form 10-Q and Article 8 of SEC Regulation S-X. Accordingly, they do not include all of the information and footnotes required by generally accepted accounting principles for complete financial statements and should be read in conjunction with the Company’s audited combined financial statements for the years ended February 28, 2017 and February 29, 2016 and notes thereto included in the Form 10-K filed with the SEC on June 14, 2017. In the opinion of management, all adjustments (consisting of normal recurring accruals) considered necessary for a fair presentation of combined financial position and results of operations for the interim periods presented have been reflected herein. Operating results for the six months ended August 31, 2017, are not necessarily indicative of the results that may be expected for the year ending February 28, 2018.

 

 
F-5
 
Table of Contents

 

Gripevine, Inc.

Notes to Interim Condensed Combined Financial Statements

For The Six Months Ended August 31, 2017

(Expressed in US dollars)

 

2. BASIS OF PRESENTATION AND COMBINATION (continued)

 

As explained above in Note 1 to the unaudited condensed combined financial statements, as a result of the Share Exchange Agreement, the acquisition transaction has been accounted for as a common control transaction in accordance with the Financial Accounting Standards Board (ASC 805-50, Business Combinations – Common control transactions). Consequently, the combined financial statements have been prepared as if the Company and MBE were a single organization by the aggregation of their financial statements from the beginning of the previous period and the elimination of transactions and balances between them.

 

3. GOING CONCERN

 

The unaudited condensed combined financial statements have been prepared on a going concern basis, which contemplates the realization of assets and satisfaction of liabilities in the normal course of business. The Company has incurred recurring losses from operations and as at August 31, 2017 and February 28, 2017 had a working capital deficiency of $2,931,880 and $2,618,599, respectively and an accumulated deficit of $47,859,577 and $46,634,969 respectively. Management anticipates the Company will attain profitable status and improve its liquidity through continued business development and additional debt or equity investment in the Company. The Company’s continued existence is dependent upon its ability to continue to execute its operating plan and to obtain additional debt or equity financing. There can be no assurance that the necessary debt or equity financing will be available, or will be available on terms acceptable to the Company, in which case the Company may be unable to meet its obligations. Should the Company be unable to realize its assets and discharge its liabilities in the normal course of business, the net realizable value of its assets may be materially less than the amounts recorded in the combined financial statements. The combined financial statements do not include any adjustments relating to the recoverability of recorded asset amounts that might be necessary should the Company be unable to continue in existence.

 

4. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

 

Use of Estimates

 

The preparation of unaudited condensed combined financial statements in conformity with US GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the combined financial statements and the reported amounts of revenues and expenses during the reporting period. Areas involving significant estimates and assumptions include: deferred income tax assets and related valuation allowance and accruals. Actual results could differ from those estimates. These estimates are reviewed periodically, and, as adjustments become necessary, they are reported in earnings in the period in which they become known.

 

Loss Per Share

 

The Company has adopted the Financial Accounting Standards Board’s (“FASB”) Accounting Standards Codification (“ASC”) Topic 260-10 which provides for calculation of “basic” and “diluted” earnings per share. Basic earnings per share includes no dilution and is computed by dividing net income or loss available to common stockholders by the weighted average number of common shares outstanding for the period. Diluted earnings per share reflect the potential dilution of securities that could share in the earnings of an entity. Diluted earnings per share exclude all potentially dilutive shares if their effect is anti-dilutive. There were no potentially dilutive shares outstanding as at August 31, 2017 and 2016.

 

Fair Value of Financial Instruments

 

ASC 820 defines fair value, establishes a framework for measuring fair value and expands required disclosure about fair value measurements of assets and liabilities. ASC 820-10 defines fair value as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. ASC 820-10 also establishes a fair value hierarchy, which requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. The standard describes three levels of inputs that may be used to measure fair value:

 

 
F-6
 
Table of Contents

 

Gripevine, Inc.

Notes to Interim Condensed Combined Financial Statements

For The Six Months Ended August 31, 2017

(Expressed in US dollars)

 

4. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (continued)

 

·

Level 1 – Valuation based on quoted market prices in active markets for identical assets or liabilities.

 

·

Level 2 – Valuation based on quoted market prices for similar assets and liabilities in active markets.

 

·

Level 3 – Valuation based on unobservable inputs that are supported by little or no market activity, therefore requiring management’s best estimate of what market participants would use as fair value.

 

In instances where the determination of the fair value measurement is based on inputs from different levels of the fair value hierarchy, the level in the fair value hierarchy within which the entire fair value measurement falls is based on the lowest level input that is significant to the fair value measurement in its entirety. The Company’s assessment of the significance of a particular input to the fair value measurement in its entirety requires judgment, and considers factors specific to the asset or liability.

 

Fair value estimates discussed herein are based upon certain market assumptions and pertinent information available to management. The respective carrying value of certain on-balance-sheet financial instruments approximated their fair values due to the short-term nature of these instruments or interest rates that are comparable to market rates. These financial instruments include cash and accounts payable. The Company's cash, which is carried at fair value, is classified as a Level 1 financial instrument. The Company’s bank accounts are maintained with financial institutions of reputable credit, therefore, bear minimal credit risk.

 

Stock Based Compensation

 

The Company accounts for share-based payments in accordance with the provision of ASC 718, which requires that all share-based payments issued to acquire goods or services, including grants of employee stock options, be recognized in the statement of operations based on their fair values, net of estimated forfeitures. ASC 718 requires forfeitures to be estimated at the time of grant and revised, if necessary, in subsequent periods if actual forfeitures differ from those estimates. Compensation expense related to share-based awards is recognized over the requisite service period, which is generally the vesting period. The Company accounts for stock based compensation awards issued to non-employees for services, as prescribed by ASC 718-10, at either the fair value of the services rendered or the instruments issued in exchange for such services, whichever is more readily determinable, using the guidelines in ASC 505-50. The Company issues compensatory shares for services including, but not limited to, executive, management, accounting, operations, corporate communication, financial and administrative consulting services

 

Recently Issued Accounting Pronouncements

 

On January 1, 2017, the Company adopted the accounting pronouncement issued by the Financial Accounting Standards Board (“FASB”) to simplify the presentation of deferred income taxes within the balance sheet. This pronouncement eliminates the requirement that deferred tax assets and liabilities are presented as current or noncurrent based on the nature of the underlying assets and liabilities. Instead, the pronouncement requires that all deferred tax assets and liabilities, including valuation allowances, be classified as noncurrent. We adopted this pronouncement on a retrospective basis. The adoption of this guidance did not have a material impact on the Company’s unaudited condensed financial position and/or results of operations.

 

On January 1, 2017, the Company adopted the accounting pronouncement issued by the FASB to simplify the accounting for goodwill impairment. This guidance eliminates the requirement that an entity calculate the implied fair value of goodwill when measuring an impairment charge. Instead, an entity would record an impairment charge based on the excess of a reporting unit’s carrying amount over its fair value. The Company adopted this pronouncement on a prospective basis. The adoption of this guidance did not have a material impact on the Company’s unaudited condensed financial position and/or results of operations.

 

 
F-7
 
Table of Contents

 

Gripevine, Inc.

Notes to Interim Condensed Combined Financial Statements

For The Six Months Ended August 31, 2017

(Expressed in US dollars)

 

4. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (continued)

 

In February 2016, an accounting pronouncement was issued by the FASB to replace existing lease accounting guidance. This pronouncement is intended to provide enhanced transparency and comparability by requiring lessees to record right-of-use assets and corresponding lease liabilities on the balance sheet for most leases. Expenses associated with leases will continue to be recognized in a manner similar to current accounting guidance. This pronouncement is effective for annual and interim periods beginning after December 15, 2018, with early adoption permitted. The adoption is required to be applied on a modified retrospective basis for each prior reporting period presented. The Company has not yet determined the effect that the adoption of this pronouncement may have on its unaudited condensed financial position and/or results of operations.

 

5. EQUIPMENT

 

 

 

As at

August 31,

 

 

As at

February 28,

 

 

 

2017

 

 

2017

 

 

 

$

 

 

$

 

Furniture

 

 

39,265

 

 

 

31,889

 

Computer equipment

 

 

30,498

 

 

 

24,864

 

Total cost

 

 

69,763

 

 

 

56,753

 

Less: Accumulated depreciation

 

 

(28,470 )

 

 

(15,098 )

 

 

 

41,293

 

 

 

41,655

 

 

6. LOANS PAYABLE/DUE TO RELATED PARTIES / DUE TO A SHAREHOLDER

 

Loans payable

 

Loans payable represents advances from a related corporation to meet the working capital requirements of the Company. These advances are interest free, unsecured and are repayable on demand.

 

Due to related parties and due to a shareholder

 

The balances due to related parties and a shareholder are mainly in connection with the consulting services and financing provided for the development of an online complaint resolution platform as explained in Note 1 to the condensed combined financial statements. These balances are interest free, unsecured and are repayable on demand.

 

7. STOCKHOLDERS’ DEFICIENCY

 

Share Exchange Agreement

 

On February 28, 2017, the Company, MBE and the shareholders of MBE entered into a Share Exchange Agreement (the “Share Exchange Agreement”). The Board of Directors of the Company approved the execution and consummation of the transaction under the Share Exchange Agreement on February 28, 2017.

 

In accordance with the terms and provisions of the Share Exchange Agreement, the Company is to issue an aggregate of 5,248,626 shares of its restricted common stock to the MBE Shareholders in exchange for 157,458,778 of the total issued and outstanding shares of MBE (constituting 100%), thus making MBE its wholly-owned subsidiary. The Board of Directors of the Company and MBE deemed it in the best interests of the respective shareholders to enter into the Share Exchange Agreement pursuant to which the Company would acquire all the technology and assets and assume all liabilities of MBE.

 

 
F-8
 
Table of Contents

 

Gripevine, Inc.

Notes to Interim Condensed Combined Financial Statements

For The Six Months Ended August 31, 2017

(Expressed in US dollars)

 

7. STOCKHOLDERS’ DEFICIENCY (continued)

 

Authorized stock

 

On October 31, 2016, the Board of Directors of the Company authorized an increase in the Company's shares of common stock to three hundred million (300,000,000) shares with par value remaining at $0.001 and creation of twenty million (20,000,000) shares of preferred stock, par value $0.001. On November 4, 2016, the Company filed a Certificate of Amendment with the Nevada Secretary of State increasing its authorized capital to 300,000,000 shares of common stock, par value $0.001, and 20,000,000 shares of preferred stock, par value $0.001 (the “Amendment). The Amendment was effective with the Nevada Secretary of State on November 4, 2016 when the Certificate of Amendment was filed. The Amendment was approved by the Board of Directors pursuant to written consent resolutions dated October 31, 2016 and further approved by the shareholders holding a majority of the total issued and outstanding shares of common stock of the Company pursuant to written consent resolutions dated October 31, 2016.

 

Common stock

 

On May 31, 2016 and effective October 3, 2016, the Company’s previous majority shareholder, sole executive officer and member of the Board of Directors, entered into those certain stock purchase agreements (collectively, the “Stock Purchase Agreements”) with certain individuals and/or entities (collectively, the “Investors”). In accordance with the terms and provisions of the Stock Purchase Agreements, the then majority shareholder sold and transferred at a per share price of $0.037 the control block of the Company consisting of 5,000,000 shares of restricted common stock and representing approximately 62.5% of the total issued and outstanding shares of common stock. 

 

During June and August 2017, the Company sold 1,445,657 shares of common stock to nine investors through a private placement at a price of $0.35 per common stock and received gross proceeds of $505,980.

 

As at August 31, 2017 and February 28, 2017, the Company has 120,000,000 outstanding common stock (comprising of 75,000,000 restricted stock and 45,000,000 unrestricted stock).

 

In addition, as at August 31, 2017, 6,694,283 shares of restricted common stock are to be issued, comprising of 5,248,626 shares pursuant to the Share Exchange Agreement and 1,445,657 shares in connection with private placement. Subsequent to the quarter ended August 31, 2017, 4,720,532 shares of these common stock have been issued.

 

Preferred stock

 

On April 20, 2017, the Board of Directors authorized the issuance of the 1,000,000 shares of Series A Preferred Stock to its sole executive officer and member of the Board of Directors in consideration of his services performed during the year ended February 28, 2017. These preferred stock contain certain rights and preference as detailed below:

 

 

· In the event of acquisition of the Company, the preferred stock holder to receive 20% of the aggregate valuation of such merger;

 

· The holder can convert each share of preferred stock into 100 shares of common stock; and

 

· Each holder of preferred stock shall be entitled to cast 200 votes.

 

The fair value of these 1,000,000 preferred stock amounting to $38,694,414 was determined by an independent valuation using the assumptions i-e conversion value, control premium of 11.15% based on similar publicly trading companies, voting and sale/merger rights of the stock and stock price of $0.69. As the issuance of preferred stock related to past services, therefore, this amount was recorded as stock based compensation in the combined statements of operations during the previous year ended February 28, 2017. The charge relating to three and six months ended August 31, 2016 amounts to $9,673,604 and $19,347,207.

 

 
F-9
 
Table of Contents

 

Gripevine, Inc.

Notes to Interim Condensed Combined Financial Statements

For The Six Months Ended August 31, 2017

(Expressed in US dollars)

 

7. STOCKHOLDERS’ DEFICIENCY (continued)

 

Warrants

 

On December 1, 2016, the Company issued 18,275,000 warrants to certain shareholders of the Company for their services for the year ended February 28, 2017. These warrants have a strike price of $0.40 and will expire on December 1, 2019. The fair value of these warrants were measured at the date of grant using the Black-Scholes option pricing model using the following assumptions:

 

 

· Forfeiture rate of 0%;

 

· Stock price of $0.12 per share;

 

· Exercise price of $0.4 per share’

 

· Volatility at 265.20 %;

 

· Risk free interest rate of 1.45%;

 

· Expected life of 3 years; and

 

· Expected dividend rate of 0%

 

At grant date the fair value of these warrants were determined at $2,110,333. As the issuance of warrants related to past services, therefore, this amount was recorded as stock based compensation in the combined statements of operations during the year (fourth quarter) ended February 28, 2017.

 

As at August 31, 2017 and February 28, 2017, there were 18,275,000 warrants were outstanding, fully vested and with a remaining contractual life term of 2.25 and 2.75 years, respectively.

 

Stock Based Options

 

On August 16, 2017, the Company approved Directors, Officers, Employees and Consultants Stock Option Plan, under which it authorized 50,000,000 options and issued 5,486,500 options. This plan was established to enable the Company to attract and retain the services of highly qualified and experience directors, officers, employees and consultants and to give such person an interest in the success of the Company.

 

The fair value of each option granted is estimated at the time of grant using Black-Scholes option pricing model with the following assumptions:

 

 

· Forfeiture rate of 0%

 

· Exercise price of $0.20 per share;

 

· Volatility at 291%;

 

· Risk free interest rate of 1.49%;

 

· Expected life of 5 years; and

 

· Expected dividend rate of 0%

 

· Fair value of options of $0.20

 

50% of the grants will vest immediately and 50% will vest one year from grant date.

 

 
F-10
 
Table of Contents

 

Gripevine, Inc.

Notes to Interim Condensed Combined Financial Statements

For The Six Months Ended August 31, 2017

(Expressed in US dollars)

 

7. STOCKHOLDERS’ DEFICIENCY (continued)

 

These grants will expire on the fifth anniversary of the grant date. The risk-free interest rate is based on the yield of U.S. Treasury securities that correspond to the expected holding period of the options. The volatility was determined based on companies’ historical volatilities. The expected forfeiture (attrition) rates were based on the position of the consultants receiving the options. The dividend yield was based on an expected future dividend rate for the period at the time of grant.

 

The following table summarizes the stock option activities of the Company:

 

 

Number of

options

 

 

Weighted average exercise price

($)

 

Granted

 

 

5,486,500

 

 

 

0.200

 

Excercised

 

 

 

 

 

0.200

 

Outstanding as of August 31, 2017

 

 

5,486,500

 

 

 

0.200

 

 

The fair value of options at the issuance date were determined at $1,087,917 out of which $588,970 were expensed during the quarter ended August 31, 2017 based on vesting period and were included in stock based compensation with corresponding credit to additional paid-in-capital.

 

As at August 31, 2017 there were 5,486,500 stock options outstanding, 2,743,250 vested and with a remaining contractual life term of 4.96 years.

 

8. RELATED PARTY TRANSACTIONS AND BALANCES

 

The Company’s transactions with related parties were carried out on normal commercial terms and in the normal course of the Company’s business. Other than disclosed elsewhere in the unaudited condensed combined financial statements, the related party transactions and balances are as follows:

 

Research and development expenses for the three and six months ended August 31, 2017 include consulting charges from shareholders and related parties of $128,095 and $59,740, respectively (2016: $87,657 and $169,068 respectively).

 

9. COMMITMENTS

 

On March 8, 2016, the Company entered into an operating lease contract for its office premises in Oakville, Ontario for a three year and eight months term commenced from May 1, 2016. The monthly lease payment is between $3,350 to $4,890 plus applicable taxes.

 

On December 6, 2016, the Company entered into a second operating lease contract for its additional office premises in Oakville, Ontario for a three year term commencing from January 1, 2017. The monthly lease payment is between $2,500 to $3,800 plus applicable taxes.

 

10. SUBSEQUENT EVENTS

 

The Company’s management has evaluated subsequent events up to October 13, 2017, the date the financial statements were issued, pursuant to the requirements of ASC 855 and has determined the following material subsequent events:

 

During September 2017, the Company sold 285,714 shares of common stock to one investor through a private placement at a price of $0.35 per common stock and received gross proceeds of $100,000.

 

During October 2017, the Company issued 4,720,532 shares of common stock as explained in Note 7.

 

 
F-11
 
Table of Contents

 

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITIONS AND RESULTS OF OPERATIONS.

 

The following discussion of our financial condition, changes in financial condition, plan of operations and results of operations should be read in conjunction with our unaudited interim combined financial statements for the three and six months ended August 31, 2017 and 2016, together with the notes thereto included in this Form 10-Q. The discussion contains forward-looking statements that involve risks, uncertainties and assumptions. Our actual results may differ materially from those anticipated in these forward-looking statements as a result of many factors.

 

OVERVIEW

 

Gripevine, Inc. (formerly Baixo Relocation Services, Inc. (the "Company") was incorporated in the state of Nevada on January 7, 2014. The Company operated as a relocation service provider for clients moving to the State of Goa, India and ceased this business and engaged in developing and building an online resolution platform after the Share Exchange Agreement as explained in the foregoing paragraph. The Company's fiscal year-end is February end.

 

Changes in Control of Registrant

 

Dated May 31, 2016 and effective October 3, 2016, Rosy Rodrigues (“Rodrigues”), our prior majority shareholder, sole executive officer and member of the Board of Directors, entered into those certain stock purchase agreements (collectively, the “Stock Purchase Agreements”) with certain individuals and/or entities (collectively, the “Investors”). In accordance with the terms and provisions of the Stock Purchase Agreements, Rodrigues sold and transferred at a per share price of $0.037 the control block of the Company consisting of 5,000,000 shares of restricted common stock and representing approximately 62.5% of the total issued and outstanding shares of common stock. Therefore, there was a change in control.

 

SHARE EXCHANGE AGREEMENT

 

Effective February 28, 2017, we entered into a share exchange agreement (the “Share Exchange Agreement”) with MBE Holdings Inc., a private corporation organized under the laws of Delaware (“MBE”) and the shareholders of MBE (the “MBE Shareholders”). Our Board of Directors approved the execution and consummation of the transaction under the Share Exchange Agreement on February 28, 2017. The Board of Directors and the shareholders holding a majority of the total issued and outstanding shares of common stock of MBE authorized and approved the Share Exchange Agreement. In accordance with the Delaware Business Corporation Act, “a majority of the total issued and outstanding shares is required to approve an arrangement, which is defined as "a reconstruction under which a company transfer or sell or proposes to transfer or to sell to another company the whole or a substantial part of its undertaking for a consideration consisting in whole or in part of shares of securities of the other company ..." Our Board of Directors deemed it in the best interests of the respective shareholders to enter into the Share Exchange Agreement pursuant to which we would acquire all the technology and assets and assume all liabilities of MBE. This resulted in a change in overall business operations of the Company bringing potential value to our shareholders.

 

In accordance with the terms and provisions of the Share Exchange Agreement, an aggregate of 5,248,626 shares of our restricted common stock are to be issued to the MBE Shareholders in exchange for 157,458,778 of the total issued and outstanding shares of MBE (constituting 100%), thus making MBE our wholly-owned subsidiary. As of the date of this Quarterly Report, an aggregate _4,715,582 shares of our restricted common stock have been issued to the shareholders of MBE. See “Part II. Item 2. Unregistered Sales of Equity Securities and Use of Proceeds – Share Exchange Agreement”.

 

MBE is currently our wholly-owned subsidiary pursuant to the terms and provisions of the Share Exchange Agreement. MBE Holdings Inc. (“MBE”) was incorporated as a limited liability company on April 13, 2010 and subsequently converted into a corporation on August 3, 2012 under the laws of the State of Delaware. MBE is engaged in research and development activities to offer an online complaint resolution platform for consumers and business, including ratings, reviews and polling’s. As such, its efforts to date have been devoted in building technology that enables access to this market through the development of a tangible product. 

 

 
5
 
Table of Contents

 

Since consummation of the Share Exchange Agreement resulting in MBE being our wholly-owned subsidiary, we have been involved in the ongoing development and marketing of “Gripevine”, which is a social customer experience platform for social customer service and consumer reviews. “Gripevine” includes a proprietary process to assist companies in resolving customer service complaints (the “Gripevine Proprietary Process” or “Gripevine”). The Gripevine Proprietary Process helps consumers achieve resolutions while enabling businesses to improve consumer loyalty. Our platform includes the handling of ratings, reviews, complaint resolution statuses while offering data collection features such as scoring, polling, comments, voting, and credibility points – all with the aim of creating a home for connections, resolution, business improvement, and loyalty enhancement. Consumers with legitimate customer service complaints can post it (“plant a gripe”) and connect with companies who in turn can interact with their customers on a level playing field to find an amicable resolution.

 

Unlike other review sites that cater specifically to accumulating and displaying consumer feedback, the Gripevine business model offers significant value to both consumers and businesses. Management of the Corporation believes that the Gripevine Proprietary Process brings fairness and balance by: (i) ensuring users are real; (ii) allowing companies to reach out and verify customer identity; (iii) flagging as fake those consumers who are not identifiable; and (iv) providing companies free access to their customers. Gripevine’s unique proposition in this social customer experience space is to create consumer-company connections in order to drive loyalty through efficient and effective handling of online customer feedback and commentary.

 

RESULTS OF OPERATIONS

 

The following discussions are based on our interim condensed combined financial statements, including our wholly owned subsidiary. These charts and discussions summarize our financial statements for the three and six month period ended August 31, 2017 and August 31, 2016, and should be read in conjunction with the Company’s audited combined financial statements for the years ended February 28, 2017 and February 29, 2016 and notes thereto included in the Form 10-K filed with the SEC on June 14, 2017.

 

The following discussion contains forward-looking statements that reflect our plans, estimates and beliefs. The Corporation’s actual results could differ materially from those discussed in the forward looking statements. Factors that could cause or contribute to such differences include, but are not limited to those discussed below and elsewhere in this Quarterly Report on Form 10-Q. The financial statements are stated in United States Dollars and are prepared in accordance with United States Generally Accepted Accounting Principles.

 

Three Month Period Ended August 31, 2017 Compared to Three Month Period Ended August 31, 2016

 

Revenue. We did not generate any revenue during the three month periods ended August 31, 2017 or August 31, 2016.

 

Operating expenses. During the three month period ended August 31, 2017, we incurred operating expenses in the amount of $877,003 compared to operating expenses incurred during the three month period ended August 31, 2016 of $10,088,890 (a decrease of $9,211,887). Operating expenses include: (i) general and administrative of $85,903 (2016: $144,700); (ii) research and development expenses of $202,130 (2016: $270,586); and (iii) stock based compensation of $588,970 (2016: $9,673,604). General and administrative expenses decreased by $58,797 mainly due to a decrease in professional fees. Research and development expenses decreased by $68,456 based on streamlining the services of existing consultants relating to our increased scale and scope of work. Stock based compensation also decreased by $9,084,634 relating to: (i) the fair value of $38,694,414 for which a charge for the three months ended August 31, 2016 was $9,673,604 pertaining to the issuance of 1,000,000 shares of Series A preferred stock to Richard Hue, our President/Chief Executive Officer; and (ii) the valuation of the grant of 5,486,500 stock options resulting in $588,970 expensed during the three month period ended August 31, 2017.

 

Net Loss. Thus, during the three month period ended August 31, 2017, this resulted in a net loss of ($877,003) compared to a net loss of ($10,088,890) for the three month period ended August 31, 2016.

 

Translation Adjustment. During the three month period ended August 31, 2017, we incurred a translation adjustment of ($232,279) compared to ($21,478) incurred during the three month period ended August 31, 2016 representing change in the foreign exchange rate as a result of translating transaction and balances of Canadian based subsidiary.

 

 
6
 
Table of Contents

 

Comprehensive income (loss). Thus, this resulted in comprehensive loss of ($644,724) or ($0.007) per share for the three month period ended August 31, 2017 compared to a comprehensive loss of ($10,067,412) or ($0.084) per share for the three month period ended August 31, 2016. The weighted average number of shares outstanding was 120,000,000 for both three month periods ended August 31, 2017 and August 31, 2016, respectively.

 

Six Month Period Ended August 31, 2017 Compared to Six Month Period Ended August 31, 2016

 

Revenue. We did not generate any revenue during the six month periods ended August 31, 2017 or August 31, 2016.

 

Operating expenses. During the six month period ended August 31, 2017, we incurred operating expenses in the amount of $1,224,608 compared to operating expenses incurred during the six month period ended August 31, 2016 of $20,019,787 (a decrease of $18,795,179). Operating expenses include: (i) general and administrative of $182,556 (2016: $212,428); (ii) research and development expenses of $453,082 (2016: $460,152); and (iii) stock based compensation of $588,970 (2016: $19,347,207). General and administrative expenses decreased by $29,872 mainly due to a decrease in professional fees. Research and development expenses decreased by $7,070 based on streamlining the services of existing consultants relating to our increased scale and scope of work. Stock based compensation also decreased by $18,758,237 relating to: (i) the fair value of $38,694,414 for which a charge for the six months ended August 31, 2016 was $19,347,207 pertaining to the issuance of 1,000,000 shares of Series A preferred stock to Richard Hue, our President/Chief Executive Officer; and (ii) the valuation of the grant of 5,486,500 stock options resulting in $588,970 expensed during the six month period ended August 31, 2017.

 

Net Loss. Thus, during the six month period ended August 31, 2017, this resulted in a net loss of ($1,224,608) compared to a net loss of ($20,019,787) for the six month period ended August 31, 2016.

 

Translation Adjustment. During the six month period ended August 31, 2017, we incurred a translation adjustment of ($183,984) compared to $2,939 incurred during the six month period ended August 31, 2016 representing change in the foreign exchange rate as a result of translating transaction and balances of Canadian based subsidiary.

 

Comprehensive loss. Thus, this resulted in comprehensive loss of $1,040,624 or $0.010 per share for the six month period ended August 31, 2017 compared to a comprehensive loss of $20,022,726 or $0.167 per share for the six month period ended August 31, 2016. The weighted average number of shares outstanding was 120,000,000 for both six month periods ended August 31, 2017 and August 31, 2016, respectively.

 

LIQUIDITY AND CAPITAL RESOURCES

 

Six Month Period Ended August 31, 2017

 

As at the six month period ended August 31, 2017, our current assets were $166,497 and our current liabilities were $3,098,377, which resulted in a working capital deficit of $2,931,880. As of the six month period ended August 31, 2017, current assets were comprised of: (i) $153,657 in cash; and (ii) $12,840 in prepaid and other receivables. As at the six month period ended August 31, 2017, current liabilities were comprised of: (i) $33,371 in accounts payable; (ii) $31,804 in accrued liabilities; (iii) $2,185,217 in loans payable; (iv) $179,815 due to related parties; and (v) $668,170 due to shareholder.

 

As of the six month period ended August 31, 2017, our total assets were $207,790 comprised of: (i) current assets of $166,497; and (ii) equipment, net of depreciation of $41,293. The increase in total assets during the six month period ended August 31, 2017 from fiscal year ended February 28, 2017 was primarily due to an increase in cash of $120,979.

 

As of the six month period ended August 31, 2017, our total liabilities were $3,098,377 comprised of current liabilities. The increase of $426,819 in total liabilities during the six month period ended August 31, 2017 from fiscal year ended February 28, 2017 was primarily due to an increase in loans payable of $362,264, accounts payable of $11,046, and amounts due to a shareholder of $99,623 offset by a decrease in accrued liabilities of $47,023.

 

Stockholders’ deficit increased from ($2,576,944) for fiscal year ended February 28, 2017 to ($2,890,587) for the six month period ended August 31, 2017.

 

 
7
 
Table of Contents

 

Cash Flows from Operating Activities

 

We have generated negative cash flows from operating activities. For the six month period ended August 31, 2017, net cash flows used in operating activities was ($655,498) compared to ($685,391) for the six month period ended August 31, 2016. Net cash flows provided by operating activities consisted primarily of net loss of ($1,224,608) (2016: $20,019,787), which was adjusted by stock based compensation of $588,970 (2016: $19,347,207) and depreciation of $11,917 (2016: $5,346). Net cash flows provided by operating activities was further changed by: (i) an increase of $7,926 (2016: ($15,805)) in prepaid expenses and other receivables; (ii) an increase of $9,345 (2016: $1,500) in accounts payable; and (iii) a decrease of ($49,048) (2016: ($3,852)) in accrued liabilities.

 

Cash Flows from Investing Activities

 

For the six month period ended August 31, 2017, we used cash of $9,318 (2016: $14,589) in investing activities, which consisted of purchase of equipment.

 

Cash Flows From Financing Activities

 

Net cash flows provided from financing activities during the six month period ended August 31, 2017 was $801,480, which consisted of: (i) $505,980 in proceeds from issuance of shares; (ii) $240,219 in loans payable; and (iii) $64,099 due to a shareholder, which was offset by ($8,818) due to a related party. During the six month period ended August 31, 2016, cash flows provided by financing activities was $686,800, which consisted of $602,972 in loans payable and $154,308 due to a shareholder, which was offset by ($70,480) due to related parties.

 

Material Commitments

 

The balances due to related parties and shareholder are interest free, unsecured and are repayable on demand. The balances due to related parties and shareholders are mainly in connection with the services and financing provided for the development of an online complaint resolution platform.

 

Off-Balance Sheet Arrangements

 

There were no off-balance sheet arrangements during the six month period ended August 31, 2017 that have, or are reasonably likely to have, a current or future effect on our financial condition, revenues or expenses, results of operations, liquidity, capital expenditures or capital resources that are material to our interests.

 

PLAN OF OPERATION

 

As at August 31, 2017, we had an accumulated deficit of $47,859,577 and we will require additional financing in order to enable us to proceed with our plan of operations. When we will require additional financing, there can be no assurance that additional financing will be available to us, that it can be obtained on commercially reasonable terms. If we are not able to obtain the additional financing on a timely basis, we will not be able to meet our other obligations as they become due. We are pursuing various alternatives to meet our immediate and long-term financial requirements.

 

We anticipate continuing to rely on equity sales of our common stock in order to fund our business operations. Issuances of additional shares will result in dilution to existing stockholders. There is no assurance that we will achieve any additional sales of equity securities or arrange for debt or other financing to fund our planned business activities.

 

 
8
 
Table of Contents

 

Our auditor has issued a going concern opinion. This means that there is substantial doubt that we can continue as an on-going business for the next twelve months unless we generate sufficient revenues. There is no assurance we will ever reach that point. In the meantime the continuation of the Company is dependent upon the continued financial support from our shareholders, our ability to obtain necessary equity financing to continue operations and the attainment of profitable operations.

 

Our operations and financial results are subject to various risks and uncertainties that could adversely affect our business, financial condition and results of operations.

 

We require approximately $150,000 for the next 12 months as a reporting issuer and additional funds are required. Before generation of revenue, the additional funding may come from equity financing from the sale of our common stock or loans from management or related third parties. In the event we do not raise sufficient capital to implement its planned operations or divest, your entire investment could be lost.

 

We have not paid any sums for public relations or investor relations.

 

ITEM 3. QUALITATIVE AND QUNTITATIVE DISCLOSURE ABOUT MARKET RISKS

 

We are a smaller reporting company as defined by Rule 12b-2 of the Securities Exchange Act of 1934 and are not required to provide the information under this item.

 

ITEM 4. CONTROLS AND PROCEDURES

 

DISCLOSURE CONTROLS AND PROCEDURES

 

Pursuant to Rule 13a-15(b) under the Securities Exchange Act of 1934 (“Exchange Act”), the Company carried out an evaluation, with the participation of the Company’s management, including the Company’s Chief Executive Officer (“CEO”) and Chief Financial Officer (“CFO”) (the Company’s principal financial and accounting officer), of the effectiveness of the Company’s disclosure controls and procedures (as defined under Rule 13a-15(e) under the Exchange Act) as of the end of the period covered by this report. Based upon that evaluation, the Company’s CEO and CFO concluded that the Company’s disclosure controls and procedures are not effective as of August 31, 2017 to ensure that information required to be disclosed by the Company in the reports that the Company files or submits under the Exchange Act, is recorded, processed, summarized and reported, within the time periods specified in the SEC’s rules and forms, and that such information is accumulated and communicated to the Company’s management, including the Company’s CEO and CFO, as appropriate, to allow timely decisions regarding required disclosure for the reason described below.

 

Because of our limited operations, we have limited number of employees which prohibits a segregation of duties. In addition, we lack a formal audit committee with a financial expert. As we grow and expand our operations we will engage additional employees and experts as needed. However, there can be no assurance that our operations will expand.

 

CHANGES IN INTERNAL CONTROL OVER FINANCIAL REPORTING

 

There were no changes in our internal control over financial reporting that occurred during the period covered by this report that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

 

 
9
 
Table of Contents

 

PART II - OTHER INFORMATION

 

ITEM 1. LEGAL PROCEEDINGS

 

The Company currently is not a party to any legal proceedings and, to the Company’s knowledge; no such proceedings are threatened or contemplated.

 

ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS

 

SHARE EXCHANGE AGREEMENT

 

In accordance with the terms and provisions of the Share Exchange Agreement, an aggregate of 5,248,626 post-Stock Split shares of our restricted common stock are to be issued to the MBE Shareholders in exchange for 157,458,778 of the total issued and outstanding shares of MBE (constituting 100%), thus making MBE our wholly-owned subsidiary. As of the date of this Quarterly Report, an aggregate 4,715,582 shares of our restricted common stock have been issued to the shareholders of MBE.

 

PRIVATE PLACEMENT

 

During the three month period ended August 31, 2017 and to current date, we have engaged in a private offering of our shares of restricted common stock under Regulation S of the Securities Exchange Act of 1934, as amended. As of the date of this Quarterly Report, we have sold an aggregate 1,445,657 shares of our common stock to nine non-U.S. investors at a price of $0.35 per share of common stock. As of the date of this Quarterly Report, we have received gross proceeds of $505,980. Our Board of Directors has approved the issuance of the 1,445,657 shares of common stock to the investors, however, the shares have not been issued by our registered agent and, therefore, not included in the total issued and outstanding shares report in this Report. The shares have not been registered under the Securities Act or under any state securities laws and may not be offered or sold without registration with the United States Securities and Exchange Commission or an applicable exemption from the registration requirements. The investors acknowledged that the securities to be issued have not been registered under the Securities Act, that they understood the economic risk of an investment in the securities, and that they had the opportunity to ask questions of and receive answers from our management concerning any and all matters related to acquisition of the securities.

 

SERIES A PREFERRED STOCK

 

On April 20, 2017, the Board of Directors authorized issuance of the 1,000,000 shares of Series A Preferred Stock to its sole executive officer and member of the Board of Directors, Richard Hue, based upon recognition of the outstanding services, leadership and innovative business operational strategies provided by Mr. Hue and his continuous dedication and loyalty to us, including undertaking of the development of the Gripevine technology.

 

The shares of Series A Preferred Stock carry certain rights and preferences, including voting rights consisting of two hundred votes for each one shares of Series A Preferred Stock. The shares of Series A Preferred Stock are convertible into shares of common stock on a one-for-one hundred basis, i.e. one share of Series A Preferred Stock for one hundred shares of common stock.

 

The share of Series A Preferred Stock were issued to Mr. Hue as a non-U.S. resident in reliance on Regulation S promulgated under the United States Securities Act of 1933, as amended (the “Securities Act”). The 1,000,000 shares of Series A Preferred Stock were issued at a per share price of $0.001. Neither the shares of Series A Preferred Stock nor the underlying shares of common stock have been registered under the Securities Act or under any state securities laws and may not be offered or sold without registration with the United States Securities and Exchange Commission or an applicable exemption from the registration requirements. Mr. Hue acknowledged that the securities to be issued have not been registered under the Securities Act, that he understood the economic risk of an investment in the securities, and that he had the opportunity to ask questions of and receive answers from the Company’s management concerning any and all matters related to acquisition of the securities.

 

 
10
 
Table of Contents

 

SHARE PURCHASE WARRANTS

 

On January 13, 2017, the Board of Directors authorized the execution of those certain share purchase warrant nos. 1 through 27 dated effective December 1, 2016 (collectively, the “Share Purchase Warrants”) with certain of our shareholders. The terms and provisions of the Share Purchase Warrants provide for the issuance of an aggregate 13,162,500 warrants (the “Warrants”). The Warrants are exercisable into 13,162,500 shares of our restricted common stock for a period of three years commencing December 1, 2016 and expiring December 1, 2019 at an exercise price of $0.40 per share.

 

As of the date of this Quarterly Report, there are an aggregate of 124,720,532 shares of common stock issued and outstanding. Thus, the issuance of the Share Purchase Warrants represents approximately 10.55% of the total issued and outstanding shares.

 

BENEFICIAL OWNERSHIP TABLE

 

The following tables set forth information as of October 14, 2017 regarding the beneficial ownership of our common stock: (a) each stockholder who is known by us to own beneficially in excess of 5% of our outstanding common stock; (b) each director known to hold common or preferred stock; (c) our chief executive officer; and (d) the executive officers and directors as a group. Except as otherwise indicated, all persons listed below have (i) sole voting power and investment power with respect to their shares of stock, except to the extent that authority is shared by spouses under applicable law, and (ii) record and beneficial ownership with respect to their shares of stock. The percentage of beneficial ownership of common stock is based upon 124,720,532 shares of common stock and 1,000,000 shares of Series A preferred stock issued and outstanding as of October 14, 2017.

 

 

 

 

 

NUMBER OF SHARES

 

 

PERCENT OF SHARES

 

NAME AND ADDRESS OF

 

TITLE

 

BENEFICIALLY

 

 

BENEFICIALLY

 

BENEFICIAL OWNER

 

OF CLASS

 

OWNED (1)

 

 

OWNED

 

Officers and Directors

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Richard Hue

 

Common

 

 

57,500,000 (2)

 

 

45.74 %

1282A Cornwall Road

 

 Preferred

 

 

1,000,000

 

 

 

100 %

Oakville, Ontario Canada L6J 7W5

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

James Liolios

 

Common

 

 

8,125,000 (3)

 

 

6.50 %

1282A Cornwall Road

 

 Preferred

 

 

-0-

 

 

 

0 %

Oakville, Ontario Canada L6J 7W5

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Mark Vange

 

 Common

 

 

600,000 (4)

 

 

0.048 %

1282A Cornwall Road

 

Preferred

 

 

0

 

 

 

0 %

Oakville, Ontario Canada L6J 7W5

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

All executive officers and

 

Common

 

 

66,225,000 (5)

 

 

52.53 %

directors as a group (3 person)

 

Preferred

 

 

1,000,000

 

 

 

100 %

 

 

 

 

 

 

 

 

 

 

 

5% or Greater Shareholders

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

1322975 Alberta Ltd.

 

Common

 

 

7,500,000 (6)

 

 

6.01 %

10033 – 80 Avenue

Edmonton, Alberta

Canada T6E 1T4

 

 

 

 

 

 

 

 

 

 

__________________

(1)

Under Rule 13d-3, a beneficial owner of a security includes any person who, directly or indirectly, through any contract, arrangement, understanding, relationship, or otherwise has or shares: (i) voting power, which includes the power to vote, or to direct the voting of shares; and (ii) investment power, which includes the power to dispose or direct the disposition of shares. Certain shares may be deemed to be beneficially owned by more than one person (if, for example, persons share the power to vote or the power to dispose of the shares). In addition, shares are deemed to be beneficially owned by a person if the person has the right to acquire the shares (for example, upon exercise of an option) within 60 days of the date as of which the information is provided. In computing the percentage ownership of any person, the amount of shares outstanding is deemed to include the amount of shares beneficially owned by such person (and only such person) by reason of these acquisition rights. As a result, the percentage of outstanding shares of any person as shown in this table does not necessarily reflect the person’s actual ownership or voting power with respect to the number of shares of common stock actually outstanding as of the date of this Quarterly Report.

 

 
11
 
Table of Contents

 

(2)

Mr. Hue holds of record: (i) 56,500,000 shares of common stock; (ii) 1,000,000 Stock Options which can be exercised into 1,000,000 shares of common stock at a per share exercise price of $0.20; and (iii) 1,000,000 shares of Series A preferred stock, which if converted in accordance with the conversion terms of one share of Series A Preferred Stock for 100 shares of common stock, would result in the issuance of 100,000,000 shares of common stock.

 

 

(3)

Mr. Liolios holds of record: (i) 7,875,000 shares of common stock; and (ii) 250,000 Stock Options which can be exercised into 250,000 shares of common stock at a per share exercise price of $0.20.

 

 

(4)

Mr. Vange holds of record: (i) 500,000 shares of common stock; and (ii) 100,000 Stock Options which can be exercised into 100,000 shares of common stock at a per share exercise price of $0.20.

 

 

(5)

The figure of 66,250,000 consists of: (i) 64,875,000 shares of common stock; and (ii) 1,350,000 stock options, which are exercisable into 1,350,000 shares of common stock at a per share price of $0.20.

 

 

(6)

The sole officer and director of 1322975 Alberta Ltd. is M. Robert Mackinnon who has sole dispositive power regarding voting and disposition of the shares of common stock.

 

ITEM 3. DEFAULT UPON SENIOR SECURITIES

 

None

 

ITEM 4. MINE SAFETY DISCLOSURES

 

None

 

ITEM 5. OTHER INFORMATION

 

GRIPEVINE INC. 2017 FLEXIBLE STOCK PLAN

 

On August 16, 2017, our Board of Directors adopted approved and adopted the Gripevine Inc. 2017 Flexible Stock Plan (the “2017 SOP”). The 2017 SOP is intended to attract, motivate, and retain our employees, consultants who provide significant services and members of our Board of Directors who are not employees. The 2017 SOP is designed to further our growth and financial success by aligning the interests of the participants, through the ownership of stock and through other incentives, with the interests of our stockholders.

 

Benefits under the 2017 SOP. As defined under the 2017 SOP, the Board of Directors may grant any one or a combination of stock options (within meaning of the Code), non-qualified stock options, restricted stock as well as performance awards (collectively, “Awards”).

 

Administration of the 2017 SOP. The 2017 SOP will be administered by the Board of Directors. If it chooses, the Board may delegate its authority to a committee to be appointed by the Board (the “Committee”). Subject to certain limitations in the SOP, the Board establishes the terms and conditions of awards granted under the 2017 SOP, interprets the 2017 SOP and all awards under the 2017 SOP, and administers the 2017 SOP.

 

 
12
 
Table of Contents

 

Eligible Participants under the 2017 SOP. Except for incentive stock options which may only be granted to employees of the Company, Awards under the 2017 SOP may be granted to employees, directors, and consultants (as such terms are defined in the 2017 SOP) who are designated by the Board of Directors.

 

Shares Available under the 2017 SOP. The aggregate number of shares of common stock that may be issued or transferred to grantees under the 2017 SOP shall not exceed 50,000,000 shares. If there is a stock split, stock dividend or other relevant change affecting our shares, appropriate adjustments will be made in the number of shares that may be issued or transferred in the future and in the number of shares and price of all outstanding Awards made before such event. If shares under an Award are not issued or transferred, those shares would again be available for inclusion in future Award grants.

 

Awards Under the 2017 SOP. The Board of Directors may grant options qualifying as incentive stock options under the Code and nonqualified stock options. The term of an option shall be fixed by the Board of Directors.

 

Restricted Stock. The Board may also award shares of restricted stock. The shares will be issued as restricted stock within the meaning of Rule 144 of the Securities Act of 1933, as amended. Such grant would set forth the terms and conditions of the award, including the imposition of a vesting schedule during which the grantee must remain in our employ in order to retain the shares under grant. However, the Board may provide complete or partial exceptions to this requirement as it deems equitable. Unless an Award specifically provides otherwise, any shares not otherwise vested shall vest upon the death, disability, termination, removal or resignation of the grantee for any reason other than for cause within one year of the occurrence of a Change of Control (as that term is defined in the 2017 SOP). The grantee cannot dispose of the shares prior to the expiration of forfeiture restrictions set forth in the grant. During this period, however, the grantee would be entitled to vote the shares and, at the discretion of the Board, receive dividends. Each certificate would bear a legend giving notice of the restrictions in the grant.

 

Performance Awards. The Board of Directors may grant performance shares in consideration of services performed or to be performed, under which payment may be made in shares of the common stock, a combination of shares and cash, or cash if our performance or our subsidiary or affiliate selected by the Board meets certain goals established by the Board during an award period. The Board of Directors would determine the goals, the length of an award period and the minimum performance required before a payment would be made.

 

Other Stock or Performance-Based Awards. The Board of Directors also may grant shares of common stock or performance based Awards on the terms and conditions it determines in its discretion, as well as other rights not an Award otherwise described in the 2017 SOP but is denominated or payable in, valued in whole or in part by reference to, or otherwise based on or related to, shares of common stock or cash as are deemed by the Board to be consistent with the purposes of the 2017 SOP. Such other stock or performance-based Awards may be in addition to, or in lieu of, cash or other compensation due the grantee.

 

There are no other annuity, pension or retirement benefits or stock options proposed to be paid to officers, directors or employees in the event of retirement at normal retirement date pursuant to any existing plan provided or contributed to by us or any of our subsidiaries, if any.

 

Grant of Options

 

On August 16, 2017, the Board of Directors authorized the grant of an aggregate 5,486,500 stock options to our officers, directors and consultants (collectively, the “Optionees”). We entered into those certain stock option plan agreements with the Optionees (the “Stock Option Plan Agreeements”). In accordance with the terms and provisions of the Stock Option Plan Agreements, generally one-half of the stock options will vest as at date of execution (the “Effective Date”) of the respective Stock Option Plan Agreements (the “Initial Vesting”) and the remaining and one-half of the Stock Options shall vest one year from the Effective Date (the “2018 Vesting Date”). The Stock Option Plan Agreements further provide that in the event the Optionee’s position with us terminates (the “Early Termination Date”) after the Initial Vesting but before the 2018 Vesting Date, the remaining unvested Stock Options shall be deemed immediately forfeited as of the Early Termination Date and if the Optionee’s position with us terminates after the 2018 Vesting Date for any reason (the “Latter Termination Date”), all vested Stock Options granted to the Optionee which have not been exercised shall terminate within 48 hours after the Latter Termination Date, and shall be exercisable during such 48 hour period only to the extent they were exercisable on the Latter Termination Date. See “Part II. Item 2. Unregistered Sales of Equity Securities and Use of Proceeds – Beneficial Ownership Chart”.

 

 
13
 
Table of Contents

 

ITEM 6. EXHIBITS AND REPORTS ON FORM 8-K

 

The following exhibits are filed as part of this Form 10-Q:

 

 

 
14
 
Table of Contents

 

SIGNATURES

 

In accordance with the requirements of the Exchange Act, the registrant caused this report to be signed on its behalf by the undersigned, thereto duly authorized.

 

GRIPEVINE INC.

Date: October 13, 2017

By:

/s/ Richard Hue

Richard Hue

Chief Executive Officer/President, Secretary,

Treasurer/Chief Financial Officer and Director 

 

 

15